Ego Emollient Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

ego emollient

douglas pharmaceuticals limited - dimeticone 3%{relative}; glycerol 10%{relative};  ; light liquid paraffin 10%{relative};  ;  ; squalane 3%{relative}; white soft paraffin 5%{relative};  ; glycerol 10%{relative}; light liquid paraffin 10%{relative}; white soft paraffin 5%{relative} - topical cream - active: dimeticone 3%{relative} glycerol 10%{relative}   light liquid paraffin 10%{relative}     squalane 3%{relative} white soft paraffin 5%{relative}   excipient: glyceryl monostearate stearic acid active: glycerol 10%{relative} light liquid paraffin 10%{relative} white soft paraffin 5%{relative} excipient: cetomacrogol cetostearyl alcohol dichlorobenzyl alcohol dimeticone glyceryl monostearate lauromacrogol 150 methyl hydroxybenzoate purified water squalane stearic acid

ESTRADOT 37.5 estradiol 37.5 microgram transdermal drug delivery system sachet Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

estradot 37.5 estradiol 37.5 microgram transdermal drug delivery system sachet

novartis pharmaceuticals australia pty ltd - estradiol, quantity: 0.585 mg - drug delivery system, transdermal - excipient ingredients: dipropylene glycol; povidone; oleyl alcohol; ethyl acetate; simethicone; dimeticone; xylene; cyclomethicone; toluene; acrylates/va copolymer; ethylene/vinyl acetate copolymer; 1,1-dichloroethylene, chloroethylene polymer; polyethylene; sodium carbonate; polyethylene terephthalate; polyvinylidene flouride - short term treatment of symptoms of oestrogen deficiency due to the menopause, whether natural or surgically induced. in women with an intact uterus, oestrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals (see clinical trails and dosage and administration). combination hrt should not be used in hysterectomised women because it is not needed in these women and it may increase the risk of breast cancer.

ESTRADOT 37.5 estradiol 37.5 microgram transdermal drug delivery system sachet Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

estradot 37.5 estradiol 37.5 microgram transdermal drug delivery system sachet

sandoz pty ltd - estradiol, quantity: 0.585 mg - drug delivery system, transdermal - excipient ingredients: dipropylene glycol; povidone; oleyl alcohol; ethyl acetate; simethicone; dimeticone; xylene; cyclomethicone; toluene; acrylates/va copolymer; polyethylene terephthalate; polyvinylidene flouride; colloidal anhydrous silica; butylated hydroxytoluene; 2,6-di-tert-butyl-4-ethylphenol; calcium stearoyl lactylate; epoxidised soy oil; erucamide; ethylene/vinyl acetate copolymer; magnesium hydroxide; octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate; polyethylene; silica; stearamide; synthetic paraffin; tetrasodium pyrophosphate; vinyl acetate; quartz; 1,1-dichloroethylene, chloroethylene polymer; diatomaceous earth; oxidised polyethylene - short term treatment of symptoms of oestrogen deficiency due to the menopause, whether natural or surgically induced. in women with an intact uterus, oestrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals (see clinical trails and dosage and administration). combination hrt should not be used in hysterectomised women because it is not needed in these women and it may increase the risk of breast cancer.

Protecta Derm Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

protecta derm

aft pharmaceuticals ltd - dimeticone copolyol 1.04%{relative} (dimeticone 350; a mix of dimeticone and silicone oil with viscosity 350 cps); zinc oxide 12.5%{relative} - topical ointment - active: dimeticone copolyol 1.04%{relative} (dimeticone 350; a mix of dimeticone and silicone oil with viscosity 350 cps) zinc oxide 12.5%{relative} excipient: cetostearyl alcohol dextran cb butane/propane gas mix used as aerosol propellant lanolin, hydrous liquid paraffin purified water white soft paraffin wool alcohol

SIMECO MINT FLAVOUR CHW.TAB (25+282+85)MG/TAB Grécko - gréčtina - Εθνικός Οργανισμός Φαρμάκων

simeco mint flavour chw.tab (25+282+85)mg/tab

glaxosmithkline ΚΑΤΑΝΑΛΩΤΙΚΑ ΠΡΟΪΟΝΤΑ ΥΓΕΙΑΣ ΕΛΛΑΣ ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ Δ.Τ. gsk ch ΕΛΛΑΣ ΜΟΝΟΠΡΟΣΩΠΗ ΑΕ Λεωφ. Κηφισίας 274, 152 32 Χαλάνδρι 210.6882376 - dimeticone, activated; aluminium hydroxide-magnesium carbonate co-dried gel; magnesium hydroxide - chw.tab (ΜΑΣΩΜΕΝΟ ΔΙΣΚΙΟ) - (25+282+85)mg/tab - dimeticone, activated 25mg; aluminium hydroxide-magnesium carbonate co-dried gel 282mg; magnesium hydroxide 85mg - ordinary salt combinations and antiflatulents

Dimethicone BPC Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

dimethicone bpc

psm healthcare ltd trading as api consumer brands - cetrimide 0.5%{relative}; dimeticone 10%{relative};   - topical cream - active: cetrimide 0.5%{relative} dimeticone 10%{relative}   excipient: cetostearyl alcohol chlorocresol liquid paraffin purified water

Maalox Plus Chewable Tablets 200mg/200mg/25mg Malta - angličtina - Medicines Authority

maalox plus chewable tablets 200mg/200mg/25mg

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - dimeticone, aluminium oxide, hydrated, magnesium hydroxide - chewable tablet - dimeticone 25 milligram(s) ; aluminium oxide, hydrated 200 milligram(s) ; magnesium hydroxide 200 milligram(s) - drugs for acid related disorders

Ego Baby Cream Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

ego baby cream

douglas pharmaceuticals limited - dimeticone 15%{relative} (350); light liquid paraffin 10%{relative}; zinc oxide 15%{relative} - topical cream - active: dimeticone 15%{relative} (350) light liquid paraffin 10%{relative} zinc oxide 15%{relative} excipient: cetostearyl alcohol dexpanthenol glycerol ceteareth-25 methyl hydroxybenzoate propyl hydroxybenzoate purified water xanthan gum

Ego Silicon Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

ego silicon

douglas pharmaceuticals limited - dimeticone 15%{relative} - topical cream - 15 % - active: dimeticone 15%{relative} excipient: cetyl alcohol glycerol liquid paraffin methyl hydroxybenzoate propyl hydroxybenzoate purified water self-emulsifying glyceryl monostearate

EGO SILICON CREAM dimeticone 350 150mg/g cream jar Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

ego silicon cream dimeticone 350 150mg/g cream jar

ego pharmaceuticals pty ltd - dimeticone 350, quantity: 150 mg/g - cream - excipient ingredients: self-emulsifying glyceryl monostearate; purified water; cetyl alcohol; light liquid paraffin; propyl hydroxybenzoate; glycerol; methyl hydroxybenzoate - helps protect the skin from water, chemicals and other external irritants. helps prevent dermatitis and dry skin. helps relieve the symptoms of eczema. helps prevent blisters and chafing during sport. helps to prevent bed sores. helps protecting skin and surrounding colostomy site. helps to protect traumatised skin from further irritation. helps prevent dribble and napkin rash.